National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 65909 [05-21656]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 210 / Tuesday, November 1, 2005 / Notices
represented and a short description of the
oral presentation. Only one representative of
an organization may be allowed to present
oral comments. Both printed and electronic
copies are requested for the record. In
addition, any interested person may file
written comments with the committee. All
written comments must be received by
November 7, 2005 and should be sent via email to nsabb@od.nih.gov with ‘‘NSABB
Public Comment’’ as the subject line or by
regular mail to 6705 Rockledge Drive, Suite
750, Bethesda, MD 20892, Attention Allison
Chamberlain. The statement should include
the name, address, telephone number and,
when applicable, the business or professional
affiliation of the interested person:
Dated: October 20, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–21661 Filed 10–31–05; 8:45 am]
BILLING CODE 4140-01-M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel. RFA:
CA06–502 ‘‘AIDS Malignancy Clinical Trials
Consortium.’’
Date: November 30, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ramada Inn Rockville, 1775
Rockville Pike, Rockville, MD 20852.
Contact Person: Joyce C. Pegues, PhD.,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Blvd. 7149,
Bethesda, MD 20892. 301/594–1286.
peguesj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
VerDate Aug<31>2005
15:39 Oct 31, 2005
Jkt 208001
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 20, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–21646 Filed 10–31–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
65909
Grp., Division of Extramural Affairs/Section
Chief, 6701 Rockledge Drive, Room 7194,
Bethesda, MD 20892, 301/435–0288.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: October 20, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–21656 Filed 10–31–05; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institutes of Health
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
Review of Research Project (R01)
Applications
Date: November 30, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Loews Annapolis Hotel, 126 West
Street, Annapolis, MD 21401.
Contact Person: Katherine M. Malinda,
PhD, Scientific Review Administrator,
Review Branch, Division of Extramural
Affairs, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7198, Bethesda, MD
20892, 301/435–0297.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
Review of Research Project (RO1)
Applications
Date: November 30, 2005.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Patricia A. Haggerty, PhD,
Scientific Review Administrator, National
Heart, Lung, and Blood Institute/NIH,
Clinical Studies & Training Studies Rev.
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the Sleep
Disorders Research Advisory Board.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting:
Name of Committee: Sleep Disorders
Research Advisory Board.
Date: December 6, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To discuss sleep research and
education priorities and programs.
Place: National Institutes of Health,
Natcher Building, Conference Room D,
Bethesda, MD 20892.
Contact Person: Carl E Hunt, MD, Director,
National Center on Sleep Disorders Research,
National Heart, Lung, and Blood Institute,
National Institutes of Health, 6705 Rockledge
Drive, Room 6022, Bethesda, MD 20892, 301/
435–0199.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. This statement should include
the name, address, telephone number and
when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-governmental
employees. Persons without a government
I.D. will need to show a photo I.D. and signin at the security desk upon entering the
building.
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/meetings/index.htm,
where an agenda and any additional
E:\FR\FM\01NON1.SGM
01NON1
]]>Agencies
[Federal Register Volume 70, Number 210 (Tuesday, November 1, 2005)]
[Notices]
[Page 65909]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-21656]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel Review of Research Project (R01) Applications
Date: November 30, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Loews Annapolis Hotel, 126 West Street, Annapolis, MD
21401.
Contact Person: Katherine M. Malinda, PhD, Scientific Review
Administrator, Review Branch, Division of Extramural Affairs,
National Heart, Lung, and Blood Institute, National Institutes of
Health, 6701 Rockledge Drive, Room 7198, Bethesda, MD 20892, 301/
435-0297.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel Review of Research Project (RO1) Applications
Date: November 30, 2005.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Patricia A. Haggerty, PhD, Scientific Review
Administrator, National Heart, Lung, and Blood Institute/NIH,
Clinical Studies & Training Studies Rev. Grp., Division of
Extramural Affairs/Section Chief, 6701 Rockledge Drive, Room 7194,
Bethesda, MD 20892, 301/435-0288.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: October 20, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-21656 Filed 10-31-05; 8:45 am]
BILLING CODE 4140-01-M
